E2F1-dependent pathways are involved in amonafide analogue 7-d-induced DNA damage, G2/M arrest, and apoptosis in p53-deficient K562 cells. (Q53168345)

12 May 2018

title

E2F1-dependent pathways are involved in amonafide analogue 7-d-induced DNA damage, G2/M arrest, and apoptosis in p53-deficient K562 cells. (English)

1 reference

12 May 2018

author

Xuhong Qian

6

1 reference

12 May 2018

author name string

Yiquan Li

1

1 reference

12 May 2018

Jin Shao

2

1 reference

12 May 2018

Ke Shen

3

1 reference

12 May 2018

Yufang Xu

4

1 reference

12 May 2018

Jianwen Liu

5

1 reference

12 May 2018

publication date

1 October 2012

1 reference

12 May 2018

Journal of Cellular Biochemistry

published in

1 reference

12 May 2018

volume

113

1 reference

12 May 2018

issue

10

1 reference

12 May 2018

page(s)

3165-3177

1 reference

12 May 2018

P53: an ubiquitous target of anticancer drugs

cites work

1 reference

Transcription factor E2F-1 is upregulated in response to DNA damage in a manner analogous to that of p53

21 January 2018

1 reference

E2F1 transcription is induced by genotoxic stress through ATM/ATR activation.

21 January 2018

1 reference

A new class of naphthalimide-based antitumor agents that inhibit topoisomerase II and induce lysosomal membrane permeabilization and apoptosis

21 January 2018

1 reference

Oxaliplatin-induced gamma-H2AX activation via both p53-dependent and -independent pathways but is not associated with cell cycle arrest in human colorectal cancer cells

21 January 2018

1 reference

Restoring p53 function in cancer: novel therapeutic approaches for applying the brakes to tumorigenesis

21 January 2018

1 reference

Functional interplay between E2F1 and chemotherapeutic drugs defines immediate E2F1 target genes crucial for cancer cell death

21 January 2018

1 reference

p53 in chronic myelogenous leukemia in acute phase

21 January 2018

1 reference

Overexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo

21 January 2018

1 reference

Apaf-1 is a mediator of E2F-1-induced apoptosis

21 January 2018

1 reference

Conjugation of substituted naphthalimides to polyamines as cytotoxic agents targeting the Akt/mTOR signal pathway

21 January 2018

1 reference

E2F1 pathways to apoptosis

21 January 2018

1 reference

p53 and E2f: partners in life and death

21 January 2018

1 reference

Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell line

21 January 2018

1 reference

Involvement of E2F transcription factor family in cancer

21 January 2018

1 reference

Up-regulation of Bcl-2 homology 3 (BH3)-only proteins by E2F1 mediates apoptosis

21 January 2018

1 reference

Synthesis and anticancer activities of 6-amino amonafide derivatives.

21 January 2018

1 reference

Naphthalimides and azonafides as promising anti-cancer agents

21 January 2018

1 reference

Blastic phase of chronic myelogenous leukemia

21 January 2018

1 reference

The ATM-dependent DNA damage signaling pathway

21 January 2018

1 reference

Saussurea lappa induces G2-growth arrest and apoptosis in AGS gastric cancer cells.

21 January 2018

1 reference

MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy

21 January 2018

1 reference

DNA damage-induced activation of ATM and ATM-dependent signaling pathways

21 January 2018

1 reference

Quercetin arrests G2/M phase and induces caspase-dependent cell death in U937 cells

21 January 2018

1 reference

The emerging role of E2F-1 in the DNA damage response and checkpoint control

21 January 2018

1 reference

HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function.

21 January 2018

1 reference

Mutational inactivation of the p53 gene in the human erythroid leukemic K562 cell line

21 January 2018

1 reference

Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures

21 January 2018

1 reference

B1, a novel amonafide analogue, overcomes the resistance conferred by Bcl-2 in human promyelocytic leukemia HL60 cells

21 January 2018

1 reference

The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy

21 January 2018

1 reference

Modulation of the E2F1-driven cancer cell fate by the DNA damage response machinery and potential novel E2F1 targets in osteosarcomas

21 January 2018

1 reference

Studies on the cell-immunosuppressive mechanism of Oridonin from Isodon serra.

21 January 2018

1 reference

MDM2 suppresses p73 function without promoting p73 degradation

21 January 2018

1 reference

Overview of naphthalimide analogs as anticancer agents

21 January 2018

1 reference

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53

21 January 2018

1 reference

Betulinic acid induces apoptosis in human chronic myelogenous leukemia (CML) cell line K-562 without altering the levels of Bcr-Abl.

21 January 2018

1 reference

E2F1-induced apoptosis: turning killers into therapeutics

21 January 2018

1 reference

In vitro cytotoxic potential of Polyalthia longifolia on human cancer cell lines and induction of apoptosis through mitochondrial-dependent pathway in HL-60 cells

21 January 2018

1 reference

The polyamine transport system as a target for anticancer drug development

21 January 2018

1 reference

Methyl protodioscin induces G2/M cell cycle arrest and apoptosis in HepG2 liver cancer cells

21 January 2018

1 reference

Predicting response to cancer chemotherapy: the role of p53.

21 January 2018

1 reference

E2F1-mediated apoptosis as a target of cancer therapy

21 January 2018

1 reference

The E2F family and the role of E2F1 in apoptosis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCB.24194

1 reference

12 May 2018

1 reference

12 May 2018